| |
| |
|
| Insider
Information: |
Crotty Robert |
| Relationship: |
Gen Counsel & Corp Sec... |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
139,049 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$16,222 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
139,049 |
|
|
| Total
Value |
$16,222 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dendreon Corp |
DNDN |
EVP, General Counsel |
2015-02-17 |
97,855 |
|
0 |
Premium* |
|
|
Nabriva Therapeutics AG |
NBRV |
Gen Counsel & Corp Sec... |
2021-08-31 |
41,194 |
2018-05-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
46 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBRV |
Nabriva Therapeutics AG |
General Counsel & Secretary |
• – – |
2018-05-23 |
4 |
B |
$4.48 |
$44,800 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2020-12-31 |
4 |
D |
$2.42 |
$90 |
D/D |
(37) |
20,307 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2019-08-21 |
4/A |
S |
$2.08 |
$7,898 |
D/D |
(3,797) |
23,239 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2019-08-21 |
4 |
D |
$2.08 |
$7,898 |
D/D |
(3,797) |
23,239 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2019-08-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,250 |
27,036 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2021-08-31 |
4 |
D |
$1.06 |
$39 |
D/D |
(37) |
41,194 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2021-08-06 |
4 |
D |
$1.17 |
$87 |
D/D |
(74) |
41,231 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2021-07-31 |
4 |
D |
$1.10 |
$41 |
D/D |
(37) |
41,305 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2021-07-06 |
4 |
D |
$1.27 |
$94 |
D/D |
(74) |
41,342 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2021-06-30 |
4 |
D |
$1.35 |
$50 |
D/D |
(37) |
41,416 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2021-06-06 |
4 |
D |
$1.34 |
$98 |
D/D |
(73) |
41,453 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2021-05-31 |
4 |
D |
$1.38 |
$51 |
D/D |
(37) |
41,526 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2021-05-06 |
4 |
D |
$1.49 |
$110 |
D/D |
(74) |
41,563 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2021-04-30 |
4 |
D |
$1.78 |
$66 |
D/D |
(37) |
41,637 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2021-04-06 |
4 |
D |
$1.73 |
$128 |
D/D |
(74) |
41,674 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2021-03-06 |
4 |
D |
$1.79 |
$127 |
D/D |
(71) |
41,748 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2021-02-06 |
4 |
D |
$2.90 |
$2,523 |
D/D |
(870) |
41,819 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2021-03-31 |
4 |
D |
$1.66 |
$61 |
D/D |
(37) |
42,689 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2021-02-28 |
4 |
D |
$2.39 |
$91 |
D/D |
(38) |
42,726 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2021-01-31 |
4 |
D |
$2.62 |
$113 |
D/D |
(43) |
42,764 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2021-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
42,807 |
0 |
- |
|
| DNDN |
Dendreon Corp |
VP, Interim General CounselOff |
• – – |
2014-02-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
68,183 |
|
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2020-01-31 |
4 |
D |
$1.35 |
$5,254 |
D/D |
(3,892) |
83,097 |
0 |
- |
|
| DNDN |
Dendreon Corp |
EVP, General Counsel |
• – – |
2015-02-17 |
4 |
S |
$0.08 |
$1,765 |
D/D |
(21,764) |
97,855 |
0 |
- |
|
| DNDN |
Dendreon Corp |
EVP, General Counsel |
• – – |
2015-01-31 |
4 |
D |
$0.16 |
$75 |
D/D |
(470) |
119,619 |
0 |
- |
|
46 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
